Transgenomic Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
730.00
1,585.00
-
Gross Income
730.00
1,585.00
-
SG&A Expense
26,072.00
59,276.00
77,789
EBIT
26,802.00
60,861.00
79,210
Unusual Expense
-
18,387.00
25,020
Non Operating Income/Expense
10.00
43.00
53
Pretax Income
26,698.00
78,924.00
102,960
Income Tax
-
12,481.00
5,565
Consolidated Net Income
26,698.00
66,443.00
97,395
Net Income
26,698.00
66,443.00
97,395
Net Income After Extraordinaries
26,698.00
66,443.00
97,395
Net Income Available to Common
27,369.00
67,162.00
98,039
EPS (Basic)
0.59
1.45
3.64
Basic Shares Outstanding
46,180.20
46,180.20
26,945.50
EPS (Diluted)
0.59
1.45
3.64
Diluted Shares Outstanding
46,180.20
46,180.20
26,945.50
EBITDA
26,072.00
59,276.00
76,369
Non-Operating Interest Income
114.00
281.00
1,323
Preferred Dividends
671.00
719.00
644
About Transgenomic
View Profile
